Tick-borne Illness and Clothing Study
NCT01454414 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159
Last updated 2021-03-30
Summary
The high risk of acquiring tick-borne diseases by outdoor workers is well documented. Workers most at risk include, foresters, park rangers, land surveyors and other outdoor workers have frequent exposure to tick-infested habitats. Many North Carolina state employees with outdoor occupations report multiple tick bites each year, which indicates that existing tick preventive strategies may be ineffective. The principal goal of this study is to assess whether the use of long-lasting permethrin impregnated uniforms can reduce the number of tick bites sustained by North Carolina outdoor workers.
Conditions
- Tick Bites
- Tick-borne Illness
Interventions
- OTHER
-
Permethrin Impregnated Uniforms
Uniforms treated with permethrin according to proprietary process used by Insect Shield, Inc.
Sponsors & Collaborators
-
North Carolina State University
collaborator OTHER -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Steven R Meshnick, MD, PhD · University of North Carolina, Chapel Hill
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2012-10-31
- Completion
- 2013-04-30
Countries
- United States
Study Locations
More Related Trials
-
Immunization With BCG Vaccine to Prevent Tuberculosis Infection
NCT04453293 ·Status: TERMINATED ·Phase: PHASE3
-
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
NCT05387655 ·Status: ACTIVE_NOT_RECRUITING
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
BCG Vaccine for Health Care Workers as Defense Against COVID 19
NCT04348370 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans
NCT06845358 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Pilot Study of the Effects of BCG Immunization on CSF and Blood-based Biomarkers in Older Adults.
NCT04507126 ·Status: COMPLETED ·Phase: PHASE2
-
Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic
NCT04373291 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of BCG Vaccine for Intradermal Injection
NCT04563273 ·Status: COMPLETED ·Phase: PHASE1
-
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267 ·Status: COMPLETED ·Phase: NA
-
Primary TBE Vaccination for the Elderly
NCT04573205 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Using BCG Vaccine to Understand Tuberculosis Infection
NCT05820594 ·Status: UNKNOWN ·Phase: NA
-
Non-specific Effects of BCG in Under-five Children
NCT05471167 ·Status: UNKNOWN
-
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic
NCT04641858 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Filarial Infections on Tuberculosis Disease and Tuberculosis Vaccination in Cameroon
NCT04547738 ·Status: UNKNOWN
-
Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria
NCT00131794 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
NCT00161863 ·Status: COMPLETED ·Phase: PHASE3
-
Bordetella Pertussis Carriage in College-aged Students
NCT02215564 ·Status: UNKNOWN
-
Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.
NCT00242047 ·Status: UNKNOWN ·Phase: PHASE4
-
Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine
NCT00126217 ·Status: TERMINATED ·Phase: PHASE4
-
A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi
NCT06178666 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents
NCT02378207 ·Status: COMPLETED ·Phase: PHASE1
-
BCG Vaccination for Healthcare Workers in COVID-19 Pandemic
NCT04379336 ·Status: COMPLETED ·Phase: PHASE3
-
An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE
NCT01106482 ·Status: COMPLETED ·Phase: PHASE4
-
ARISe at UMass Chan
NCT07236034 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV
NCT03213405 ·Status: COMPLETED ·Phase: PHASE1